SQZ logo

SQZ SQZ Biotechnologies Company

New York Stock Exchange · Biotechnology · Healthcare

$0.43
+0.17 (+61.11%)

SQZ Biotechnologies, a biotechnology firm currently in the clinical development phase, is focused on creating cell-based therapies for various severe ailments, including cancerous growths, autoimmune disorders, and infectious diseases. Its primary experimental therapeutic, known as SQZ-PBMC-HPV, is derived from its SQZ Antigen Presenting Cells technology. This treatment is currently undergoing Pha…

Market Cap: $12.83Mwww.sqzbiotech.com

Price

No data yet.

Social Signal Score

53
5d
51
2 mentions
—
30d
50
2 mentions
—
60d
57
3 mentions
—
90d
55
4 mentions
—
news: 4

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 1Sell 1Strong Sell 0
Avg price target$4+819.5%
Low $4Median $4High $4
Current Consensus

Revenue

$0.00-100.00%
$0.00$4.12M$8.23M$12.35M
Mar 2018Sep 2023

Company Profile

CEO
Howard Bernstein
Sector
Healthcare
Industry
Biotechnology
Employees
53
Beta
2.71
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-22.95
www.sqzbiotech.com